Business Wire

CURE Media Group — which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates and research &mdash; has unveiled a nine-episode video series featuring Vince Fazio, who shares his hairy cell leukemia journey with Robert J. Kreitman, M.D.

“We are excited to launch our latest edition of ‘CURE Expert Connections®,’” said Michael J. Hennessy Jr., president of MJH Life Sciences, parent company of CURE Media Group. “Watching Vince Fazio open up about his personal journey on the treatment of hairy cell leukemia with Dr. Kreitman is extremely informative.”

During the nine-part series, Kreitman and Fazio discuss the treatment paradigm of the rare type of leukemia. In the first episode, Fazio, accompanied by Kreitman, describes his symptoms and how he received his diagnosis of hairy cell leukemia. In subsequent episodes, they cover more than Fazio’s personal experience — they also cover how to find reliable information about hairy cell leukemia and talk about treatment, support networks, using multidisciplinary care and more.

In addition, Fazio shares how he felt while waiting for the details of his diagnosis: “That started the most nerve-wracking two-week period of my life — not knowing what was wrong with me, not knowing whether there was a treatment. I was on pins and needles through that period. I could not concentrate on anything &mdash; work, nothing. All I had on my mind was: ‘What’s wrong with me, and how can I get rid of it?’”

®” is a video platform designed specifically for patients with cancer featuring information, stories and advice about the cancer journey.

To view the complete video series, click 

Articles

A patient and a physician discuss the treatment landscape of hairy cell.

'CURE Expert Connections' Launches 'An Opportunity for Treatment in Relapsed Hairy Cell Leukemia' Video Series

CURE Media Group — which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates and research &mdash; has launched a seven-episode discussion series featuring Steven Gallant, who shares his story of survival with stage 4 renal cell cancer (RCC), alongside Karl J. D’Silva, M.D., medical oncologist, hematologist and medical director at Lahey Cancer Center.

“We are excited to launch this video series,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of CURE Media Group. “It is revitalizing to experience Gallant’s triumph over RCC as his story is shared with both D’Silva and the audience.”

Throughout the series, Gallant and D’Silva discuss Gallant’s journey to overcome this aggressive and metastatic disease, specifically with cabozantinib treatment. The first episode delves into Gallant’s diagnosis with stage 4 RCC, and the following episodes explore a variety of effective measures to manage toxicities when treating RCC. Topics of the seven-episode series include advice for patients with RCC, as well as the impact of support networks and multidisciplinary care. The series goes beyond Gallant’s personal narrative with stage 4 RCC, as D’Silva offers insight into frontline treatment options, toxicity management with cabozantinib and the typical prognosis of RCC.

Offering advice to individuals who may find themselves in similar situations, Gallant noted, “Whenever you go to the hospital, you should be positive, never feel like a victim. That victim mentality just creates a negative flow in the body. So, I went thinking I had kidney stones. I didn’t think it was a big deal. And when they diagnosed me, as they did, I still really didn’t blink because I’m such a positive person. I just stayed positive, and I believed that whatever was going to happen was the way it was supposed to be. And as it happened, it was synchronistic because of how I ended up with (D’Silva) as a doctor.”

” is a video platform designed specifically for patients with cancer featuring information, stories and advice about the cancer journey.

One patient and a physician expert discuss the aggressive and metastatic disease and consider effective measures to managing toxicities throughout treatment.

'CURE Expert Connections' Presents 'Overcoming the Odds,' a Video Series Outlining the Journey of a Stage 4 Renal Cell Cancer Survivor

CURE Media Group, which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted to cancer updates and research, is accepting nominations for the 2019 MPN Heroes® awards. This program honors organizations and individuals who have made a difference in the field of rare blood cancers known as myeloproliferative neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership within the MPN community or a commitment to individual patients.

“We are excited to be accepting nominations for this year’s MPN Heroes Recognition Program,” said Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of CURE Media Group. “We are proud to select and recognize another group of exceptional individuals who positively impact the MPN community each and every day.”

Nominations are accepted from the community at large. A panel of judges will review the nominations and pick the finalists and winners in two categories: Commitment to the Individual and Commitment to the Broader MPN Community. For more information, to submit a nomination and to learn more about this year’s rules, click 

This year’s winners will be honored at the seventh annual MPN Heroes Celebration Event on December 6, 2019 at Sea World in Orlando, Florida.

 is sponsored by Incyte Corporation and CURE Media Group, publishers of 

® magazine. Incyte partners with CURE Media Group to support the program, with 

® hosting the annual MPN Heroes Celebration Event recognizing heroes of the MPN community. Supporting the MPN community is an ongoing priority for Incyte, a global biopharmaceutical company that discovers and develops novel medicines to meet serious unmet medical needs in oncology and other diseases. Individuals or entities supported through funding or directed by Incyte are not eligible for consideration or recognition.

The award recognizes individuals and organizations who are making a difference in the myeloproliferative neoplasm community.

CURE Magazine Seeks Nominations for 2019 MPN Heroes Recognition Program

CURE Media Group, which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates and research, announces the addition of the Susan G. Komen Florida to its Strategic Alliance Partnership (SAP) program.

“We are proud to partner with Susan G. Komen Florida,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of CURE Media Group. “This is the fourth Susan G. Komen affiliate we are working with. We really enjoy collaborating with this amazing foundation to help further their mission of helping patients with breast cancer.”

Susan G. Komen Florida serves 64 counties in Florida as the local first responders to breast cancer for women and men who need screening, diagnostic and support services. Seventy-five percent of funds raised stay in Florida to fund educational initiatives, screening and treatment programs, as well as provide financial and emotional support to those affected and their families. The remaining 25% goes to the 

 to fund cutting-edge breast cancer research. With key investments across the state, Komen Florida seeks to impact the approximately 13,700 women in Florida who are diagnosed each year, ensuring that the most vulnerable women have access to high-quality screenings, diagnostics and treatment.

 which serves the Broward, Miami-Dade and Monroe counties, the 3 counties in Florida that the Florida affiliate does not cover.

“As the first responders to care for those affected by breast cancer, we are proud to partner with CURE Media to bring the most current information on treatment options, treatment assistance programs available, and advances in the field to readers,” said Kate Watt, Komen Florida Executive Director. “We work tirelessly to generate awareness of this disease through education and the creation of innovative and impactful programming. It is estimated that breast cancer deaths can be reduced by as much as one-third with early detection and timely care. Together with CURE, we can reach an even greater number of men and women help to grow this number of survivors.”

The CURE Media Group SAP program builds a community of advocacy groups, medical associations and medical institutions to foster collaboration and an open exchange of information among trusted peers, for the ultimate benefit of patients and their families. As part of this joint effort, CURE Media Group will work with Susan G. Komen Florida and support them in helping patients with breast cancer.

For more information about CURE Media Group’s SAP program, click 

For more information about Susan G. Komen Florida, click 

CURE Media Group, which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates and research, announces the addition of the Susan G. Komen Florida to its Strategic Alliance Partnership program.

Business Wire

'CURE Expert Connections' Launches 'An Opportunity for Treatment in Relapsed Hairy Cell Leukemia' Video Series

'CURE Expert Connections' Presents 'Overcoming the Odds,' a Video Series Outlining the Journey of a Stage 4 Renal Cell Cancer Survivor

CURE Magazine Seeks Nominations for 2019 MPN Heroes Recognition Program

CURE Media Group Adds Susan G. Komen Florida to Its Strategic Alliance Partnership Program

Latest News